AAV-HIV vaccine (Avigen)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV-HIV vaccine (Avigen)

Drug Alias NameHIV gene therapy (Avigen)

ClassificationVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAvigen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAvigen Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

ATC CodeN/A